Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

547
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
547
Depression: Overview01:18

Depression: Overview

526
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
526
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

307
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
307
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

404
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
404
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

237
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
237
Drug Therapy01:28

Drug Therapy

144
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
144

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.

Journal of neurology·2026
Same author

Pilates as therapy for multiple sclerosis: current perspective and future directions.

Neurodegenerative disease management·2026
Same author

Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.

Neurorehabilitation and neural repair·2026
Same author

Acute Aerobic Walking Exercise Induces Changes in Thalamic Resting-State Connectivity in Persons with Multiple Sclerosis.

Medicine and science in sports and exercise·2026
Same author

Feasibility of a 12-month, remotely delivered and supported aerobic walking exercise training program for brain and cognition in adults with multiple sclerosis.

Journal of neurology·2026

Related Experiment Video

Updated: Nov 11, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.1K

Depression in multiple sclerosis: Is one approach for its management enough?

C Danielle Jones1, Robert Motl1, Brian M Sandroff2

  • 1University of Alabama at Birmingham, Department of Physical Therapy, Birmingham, AL, United States.

Multiple Sclerosis and Related Disorders
|March 29, 2021
PubMed
Summary

Major depression disorder (MDD) in multiple sclerosis (MS) lacks a single best treatment. Combinations of therapies like medication, CBT, and exercise may be more effective, but more research is needed.

Keywords:
DepressionExercise trainingMajor depression disorderMultiple sclerosis

More Related Videos

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

17.8K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.2K

Related Experiment Videos

Last Updated: Nov 11, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.1K
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

17.8K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.2K

Area of Science:

  • Neurology
  • Psychiatry
  • Rehabilitation

Background:

  • Major depression disorder (MDD) is common in multiple sclerosis (MS), worsening symptoms and quality of life.
  • No single gold-standard treatment currently exists for depression in MS.
  • Existing treatments like pharmacotherapy, CBT, and exercise show moderate but incomplete efficacy.

Purpose of the Study:

  • To review evidence for current depression treatments in MS from meta-analyses and systematic reviews.
  • To establish the rationale for considering combined treatment approaches for depression in MS patients.

Main Methods:

  • Narrative review of meta-analyses and systematic reviews.
  • Focused on antidepressant medication, cognitive-behavior therapy (CBT), and exercise training.
  • Assessed treatment effects in the general population and specifically in MS, noting research limitations.

Main Results:

  • Individual treatments (medication, CBT, exercise) are moderately effective but not fully sufficient for depression in MS.
  • Current evidence for combined treatment approaches in MS is limited.
  • Research gaps exist regarding the efficacy and feasibility of combination therapies for MDD in MS.

Conclusions:

  • A single, optimal treatment for depression in MS is lacking.
  • Combinatory treatment strategies are proposed as a potential solution.
  • Further research is essential to evaluate the feasibility and efficacy of combined therapies for MDD in MS.